Private equity firm Aksia is in exclusive talks to acquire Medical International Research (MIR), an Italian medical devices and software company specialising in spirometry devices, sources close to the deal told sister publication Mergermarket.
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018